Enhanced bone tissue regeneration of a biomimetic cellular scaffold with co-cultured MSCs-derived osteogenic and angiogenic cells.

Abstract

ObjectivesThe bone tissue engineering primarily focuses on three‐dimensional co‐culture systems, which physical and biological properties resemble the cell matrix of actual tissues. The complex dialogue between bone‐forming and endothelial cells (ECs) in a tissue‐engineered construct will directly regulate angiogenesis and bone regeneration. The purpose of this study was to investigate whether co‐culture between osteogenic and angiogenic cells derived by bone mesenchymal stem cells (MSCs) could affect cell activities and new bone formation.Materials and methodsMesenchymal stem cells were dually induced to differentiate into osteogenic cells (OMSCs) and ECs; both cell types were co‐cultured at different ratios to investigate their effects and underlying mechanisms through ELISA, RT‐qPCR and MTT assays. The selected cell mixture was transplanted onto a nano‐hydroxyapatite/polyurethane (n‐HA/PU) scaffold to form a cell‐scaffold construct that was implanted in the rat femoral condyles. Histology and micro‐CT were examined for further verification.ResultsELISA and gene expression studies revealed that co‐cultured OMSCs/ECs (0.5/1.5) significantly elevated the transcription levels of osteogenic genes such as ALP, Col‐I and OCN, as well as transcription factors Msx2, Runx2 and Osterix; it also upregulated angiogenic factors of vascular endothelial growth factor (VEGF) and CD31 when compared with cells cultured alone or in other ratios. The optimized OMSCs/ECs group had more abundant calcium phosphate crystal deposition, further facilitated their bone formation in vivo.ConclusionsThe OMSCs/ECs‐scaffold constructs at an optimal cell ratio (0.5/1.5) achieved enhanced osteogenic and angiogenic factor expression and biomineralization, which resulted in more effective bone formation.